Problem
1.4+ billion people are diagnosed with infectious diseases every year.
8 days is the average delay for a person to go from the first symptom to treatment leading to severe disease, causing 15 million+ avoidable deaths every year.
We have developed an infectious disease detection technology that can reduce this symptom-to-treatment cycle from the 8 day average to under 30 minutes.
How Our Technology Works And Its USP
Our prototype uses fingernail sized lasers and gold nanorods to amplify pathogen DNA to provide unprocessed sample-to-result time of <5 minutes. Crucially, the plasmonic PCR process integrates/removes the need for crucial steps (such as cell lysis, extraction and purification) to detect pathogens from entirely unprocessed samples, enabling it to be used without the need for a healthcare professional or a technician. Using our fast, single-step, portable and high accuracy PCR, first in point-of-care settings and subsequently in point-of-need or patient-facing settings, we can help diagnose and treat patients 200x faster (from 8 days to a few mins) to prevent severe disease.
Company Details
- Employees
- 11
- Address
- Maxwell Centre, Cavendish Laboratory,united Kingdom
- Industry
- Medical And Diagnostic Laboratories
- NAICS
-
Medical and Diagnostic LaboratoriesMedical LaboratoriesDiagnostic Imaging Centers
- Website
- https://rapidx.bio/
- Keywords
- Didcot.
- HQ
- Cambridge, Cambridgeshire, UK
Rapidx Bio Questions
Rapidx Bio's website is https://rapidx.bio/
Rapidx Bio's LinkedIn profile is https://uk.linkedin.com/company/rapidx-bio
Rapidx Bio has
11 employees.
View email and phone details for 11
employees at Rapidx Bio.
Rapidx Bio's industry is
Medical and Diagnostic Laboratories
Rapidx Bio's top competitors are
Organicco,
Purifire Energy,
Simplifai Systems Limited,
Agreka Build Ltd,
Haliogen Power,
Insilicominds,
Netzero Protocol,
Straw Innovations,
Unusual,
Thinkclock Battery Labs.
Rapidx Bio's categories are Medical and Diagnostic Laboratories
